Literature Cited

  • 1
    Beadsmoore CJ, Screaton NJ. Classification, staging and prognosis of lung cancer. Eur J Radiol 2003;45:817.
  • 2
    Heasley LE. Autocrine and paracrine signaling through neuropeptide receptors in human cancer. Oncogene 2001;20:15631569.
  • 3
    Pfeiffer M, Hartmann TN, Leick M, Catusse J, Schmitt-Graeff A, Burger M. Alternative implication of CXCR4 in JAK2/STAT3 activation in small cell lung cancer. Br J Cancer 2009;100:19491956.
  • 4
    Bepler G, Jaques G, Neumann K, Aumuller G, Gropp C, Havemann K. Establishment, growth properties, and morphological characteristics of permanent human small cell lung cancer cell lines. J Cancer Res Clin Oncol 1987;113:3140.
  • 5
    Gazdar AF, Girard L, Lockwood WW, Lam WL, Minna JD. Lung cancer cell lines as tools for biomedical discovery and research. J Natl Cancer Inst 2010;102: 13101321.
  • 6
    Seddon AD, Green VL, Newton CJ, Greenman J, Atkin SL, Speirs V. Differential expression of cell adhesion molecules in phenotypic variants of the small cell lung carcinoma cell line NCI-H69. In Vitro Cell Dev Biol Anim 1998;34:677678.
  • 7
    Gazdar AF, Carney DN, Nau MM, Minna JD. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Cancer Res 1985;45:29242930.
  • 8
    Gilchrist AJ, Meuser R, Turchinsky J, Shaw AR, Pasdar M, Dixon WT. Cell adhesion-mediated transformation of a human SCLC cell line is associated with the development of a normal phenotype. Exp Cell Res 2002;276:6378.
  • 9
    Kohmo S, Kijima T, Otani Y, Mori M, Minami T, Takahashi R, Nagatomo I, Takeda Y, Kida H, Goya S, Yoshida M, Kumagai T, Tachibana I, Yokota S, Kawase I.Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer. Cancer Res 2010;70:80258035.
  • 10
    Tsurutani J, West KA, Sayyah J, Gills JJ, Dennis PA. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy. Cancer Res 2005;65:84238432.
  • 11
    Sethi T, Rintoul RC, Moore SM, MacKinnon AC, Salter D, Choo C, Chilvers ER, Dransfield I, Donnelly SC, Strieter R, Haslett C.Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med 1999;5:662668.
  • 12
    Kraus AC, Ferber I, Bachmann SO, Specht H, Wimmel A, Gross MW, Schlegel J, Suske G, Schuermann M. In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways. Oncogene 2002;21:86838695.
  • 13
    Shield K, Ackland ML, Ahmed N, Rice GE. Multicellular spheroids in ovarian cancer metastases: Biology and pathology. Gynecol Oncol 2009;113:143148.
  • 14
    Miyahara R, Tanaka F, Nakagawa T, Matsuoka K, Isii K, Wada H. Expression of neural cell adhesion molecules (polysialylated form of neural cell adhesion molecule and L1-cell adhesion molecule) on resected small cell lung cancer specimens: In relation to proliferation state. J Surg Oncol 2001;77:4954.
  • 15
    Falconer RA, Errington RJ, Shnyder SD, Smith PJ, Patterson LH. Polysialyltransferase: A new target in metastatic cancer. Curr Cancer Drug Targets 2012;12:925939.
  • 16
    Scheidegger EP, Lackie PM, Papay J, Roth J. In vitro and in vivo growth of clonal sublines of human small cell lung carcinoma is modulated by polysialic acid of the neural cell adhesion molecule. Lab Invest 1994;70:95106.
  • 17
    Walmod PS, Kolkova K, Berezin V, Bock E. Zippers make signals: NCAM-mediated molecular interactions and signal transduction. Neurochem Res 2004;29: 20152035.
  • 18
    Johnson CP, Fujimoto I, Rutishauser U, Leckband DE. Direct evidence that neural cell adhesion molecule (NCAM) polysialylation increases intermembrane repulsion and abrogates adhesion. J Biol Chem 2005;280:137145.
  • 19
    Rutishauser U. Polysialic acid in the plasticity of the developing and adult vertebrate nervous system. Nat Rev Neurosci 2008;9:2635.
  • 20
    Hayashida T, Jinno H, Kitagawa Y, Kitajima M. Cooperation of cancer stem cell properties and epithelial-mesenchymal transition in the establishment of breast cancer metastasis. J Oncol 2011;2011:591427.
  • 21
    Hildebrandt H, Muhlenhoff M, Gerardy-Schahn R. Polysialylation of NCAM. Adv Exp Med Biol 2010;663:95109.
  • 22
    Jakobsson E, Schwarzer D, Jokilammi A, Finne J. Endosialidases: Versatile tools for the study of polysialic acid. Top Curr Chem 2012; p 1–46.
  • 23
    Jokilammi A, Ollikka P, Korja M, Jakobsson E, Loimaranta V, Haataja S, Hirvonen H, Finne J. Construction of antibody mimics from a noncatalytic enzyme-detection of polysialic acid. J Immunol Methods 2004;295:149160.
  • 24
    Smith PJ, Wiltshire M, Chappell SC, Cosentino L, Burns PA, Pors K, Errington RJ. Kinetic analysis of intracellular Hoechst 33342--DNA interactions by flow cytometry: Misinterpretation of side population status?Cytometry A 2013;83A:161169.
  • 25
    Tassi E, Zanon M, Vegetti C, Molla A, Bersani I, Perotti V, Pennati M, Zaffaroni N, Milella M, Ferrone S, Carlo-Stella C, Gianni AM, Mortarini R, Anichini A.Role of Apollon in human melanoma resistance to antitumor agents that activate the intrinsic or the extrinsic apoptosis pathways. Clin Cancer Res 2012;18:33163327.
  • 26
    Pan Y, Kaatz L. Use of image-based flow cytometry in bacterial viability analysis using fluorescent probes. Curr Protoc Microbiol 2012; Chapter 2: Unit2 C-5.
  • 27
    Akagi J, Kordon M, Zhao H, Matuszek A, Dobrucki J, Errington R, Smith PJ, Takeda K, Darzynkiewicz Z, Wlodkowic D. Real-time cell viability assays using a new anthracycline derivative DRAQ7(R). Cytometry A 2013;83A:227234.
  • 28
    Smith PJ, Wiltshire M, Chin SF, Rabbitts P, Soues S. Cell cycle checkpoint evasion and protracted cell cycle arrest in X-irradiated small-cell lung carcinoma cells. Int J Radiat Biol 1999;75:11371147.
  • 29
    Gazdar AF, Carney DN, Russell EK, Sims HL, Baylin SB, Bunn PA Jr, Guccion JG, Minna JD. Establishment of continuous, clonable cultures of small-cell carcinoma of lung which have amine precursor uptake and decarboxylation cell properties. Cancer Res 1980;40:35023507.
  • 30
    Baillie-Johnson H, Twentyman PR, Fox NE, Walls GA, Workman P, Watson JV, Johnson N, Reeve JG, Bleehen NM. Establishment and characterisation of cell lines from patients with lung cancer (predominantly small cell carcinoma). Br J Cancer 1985;52:495504.
  • 31
    Twentyman PR, Wright KA, Mistry P, Kelland LR, Murrer BA. Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin. Cancer Res 1992;52:56745680.
  • 32
    Fisher ER, Paulson JD. A new in vitro cell line established from human large cell variant of oat cell lung cancer. Cancer Res 1978;38(11 Pt 1):38303835.
  • 33
    Smith PJ, Marquez N, Wiltshire M, Chappell S, Njoh K, Campbell L, Khan IA, Silvestre O, Errington RJ. Mitotic bypass via an occult cell cycle phase following DNA topoisomerase II inhibition in p53 functional human tumor cells. Cell Cycle 2007;6:20712081.
  • 34
    Errington RJ, Brown MR, Silvestre OF, Njoh KL, Chappell SC, Khan IA, Rees P, Wilks SP, Smith PJ, Summers HD. Single cell nanoparticle tracking to model cell cycle dynamics and compartmental inheritance. Cell Cycle 2010;9:121130.
  • 35
    Smith PJ, Blunt N, Wiltshire M, Hoy T, Teesdale-Spittle P, Craven MR, Watson JV, Amos WB, Errington RJ, Patterson LH. Characteristics of a novel deep red/infrared fluorescent cell-permeant DNA probe, DRAQ5, in intact human cells analyzed by flow cytometry, confocal and multiphoton microscopy. Cytometry 2000;40:280291.
  • 36
    Rutishauser U, Watanabe M, Silver J, Troy FA, Vimr ER. Specific alteration of NCAM-mediated cell adhesion by an endoneuraminidase. J Cell Biol 1985;101(5 Pt 1):18421849.
  • 37
    Kuschel C, Steuer H, Maurer AN, Kanzok B, Stoop R, Angres B. Cell adhesion profiling using extracellular matrix protein microarrays. Biotechniques 2006;40:523531.
  • 38
    United Kingdom Co-Ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (2nd ed). Br J Cancer 1998;77:10.
  • 39
    Shnyder SD, Cooper PA, Millington NJ, Pettit GR, Bibby MC. Auristatin PYE, a novel synthetic derivative of dolastatin 10, is highly effective in human colon tumour models. Int J Oncol 2007;31:353360.
  • 40
    Seidenfaden R, Krauter A, Schertzinger F, Gerardy-Schahn R, Hildebrandt H. Polysialic acid directs tumor cell growth by controlling heterophilic neural cell adhesion molecule interactions. Mol Cell Biol 2003;23:59085918.
  • 41
    Summers HD, Rees P, Holton MD, Rowan Brown M, Chappell SC, Smith PJ, Errington RJ. Statistical analysis of nanoparticle dosing in a dynamic cellular system. Nat Nanotechnol 2011;6:170174.
  • 42
    Soues S, Wiltshire M, Smith PJ. Differential sensitivity to etoposide (VP-16)-induced S phase delay in a panel of small-cell lung carcinoma cell lines with G1/S phase checkpoint dysfunction. Cancer Chemother Pharmacol 2001;47:133140.
  • 43
    Koros AM, Klein EC, Pan S, Atchison RW, Lakomy R, Bahnson A, Sherer C. Stability and utility of the unique human small cell carcinoma line SHP-77. Cancer Res 1985;45:27252731.
  • 44
    Acheson A, Sunshine JL, Rutishauser U. NCAM polysialic acid can regulate both cell-cell and cell-substrate interactions. J Cell Biol 1991;114:143153.
  • 45
    Dennis J, Waller C, Timpl R, Schirrmacher V. Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin. Nature 1982;300:274276.
  • 46
    Fujimoto I, Bruses JL, Rutishauser U. Regulation of cell adhesion by polysialic acid. Effects on cadherin, immunoglobulin cell adhesion molecule, and integrin function and independence from neural cell adhesion molecule binding or signaling activity. J Biol Chem 2001;276:3174531751.
  • 47
    Ocak S, Yamashita H, Udyavar AR, Miller AN, Gonzalez AL, Zou Y, Jiang A, Yi Y, Shyr Y, Estrada L, Quaranta V, Massion PP.DNA copy number aberrations in small-cell lung cancer reveal activation of the focal adhesion pathway. Oncogene 2010;29:63316342.
  • 48
    Moody TW. Peptide hormones and lung cancer. Panminerva Med 2006;48:1926.
  • 49
    Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 1985;316:823826.
  • 50
    Pinski J, Schally AV, Halmos G, Szepeshazi K, Groot K, O'Byrne K, Cai RZ. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice. Br J Cancer 1994;70:886892.
  • 51
    Marusyk A, Almendro V, Polyak K. Intra-tumour heterogeneity: A looking glass for cancer?Nat Rev Cancer 2012;12:323334.
  • 52
    Huang S. Non-genetic heterogeneity of cells in development: More than just noise. Development 2009;136:38533862.
  • 53
    Wu M, Liu L, Chan C. Identification of novel targets for breast cancer by exploring gene switches on a genome scale. BMC Genomics 2011;12:547.
  • 54
    Frank SA, Rosner MR. Nonheritable cellular variability accelerates the evolutionary processes of cancer. PLoS Biol 2012;10:e1001296.
  • 55
    Li J, Dai G, Cheng YB, Qi X, Geng MY. Polysialylation promotes neural cell adhesion molecule-mediated cell migration in a fibroblast growth factor receptor-dependent manner, but independent of adhesion capability. Glycobiology 2011; 21:10101018.
  • 56
    Eggers K, Werneburg S, Schertzinger A, Abeln M, Schiff M, Scharenberg MA, Burkhardt H, Muhlenhoff M, Hildebrandt H. Polysialic acid controls NCAM signals at cell-cell contacts to regulate focal adhesion independent from FGF receptor activity. J Cell Sci 2011;124(Pt 19):32793291.